MedPath
NMPA Approval

Gliclazide Tablets

国药准字H44020011

April 9, 2024

Drug Information

格列齐特片

达尔得

达尔得

片剂

80mg

化学药品

April 9, 2024

Company Information

Applicant Company

广州市海珠区南石路1号

Manufacturing Company

广州市海珠区南石路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

格列齐特片 - NMPA 批准文号 | MedPath